205 related articles for article (PubMed ID: 22901267)
1. Immune reconstitution and strategies for rebuilding the immune system after haploidentical stem cell transplantation.
Oevermann L; Lang P; Feuchtinger T; Schumm M; Teltschik HM; Schlegel P; Handgretinger R
Ann N Y Acad Sci; 2012 Aug; 1266():161-70. PubMed ID: 22901267
[TBL] [Abstract][Full Text] [Related]
2. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.
Bethge WA; Faul C; Bornhäuser M; Stuhler G; Beelen DW; Lang P; Stelljes M; Vogel W; Hägele M; Handgretinger R; Kanz L
Blood Cells Mol Dis; 2008; 40(1):13-9. PubMed ID: 17869547
[TBL] [Abstract][Full Text] [Related]
3. Facilitating T-cell immune reconstitution after haploidentical transplantation in adults.
Waller EK; Giver CR; Rosenthal H; Somani J; Langston AA; Lonial S; Roback JD; Li JM; Hossain MS; Redei I
Blood Cells Mol Dis; 2004; 33(3):233-7. PubMed ID: 15528137
[TBL] [Abstract][Full Text] [Related]
4. Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: fast engraftment and low toxicity.
Bethge WA; Haegele M; Faul C; Lang P; Schumm M; Bornhauser M; Handgretinger R; Kanz L
Exp Hematol; 2006 Dec; 34(12):1746-52. PubMed ID: 17157172
[TBL] [Abstract][Full Text] [Related]
5. Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies.
Chen X; Hale GA; Barfield R; Benaim E; Leung WH; Knowles J; Horwitz EM; Woodard P; Kasow K; Yusuf U; Behm FG; Hayden RT; Shurtleff SA; Turner V; Srivastava DK; Handgretinger R
Br J Haematol; 2006 Nov; 135(4):524-32. PubMed ID: 17010105
[TBL] [Abstract][Full Text] [Related]
6. Haploidentical bone marrow transplantation without T-cell depletion.
Chang YJ; Huang XJ
Semin Oncol; 2012 Dec; 39(6):653-63. PubMed ID: 23206842
[TBL] [Abstract][Full Text] [Related]
7. Graft dysfunction and delayed immune reconstitution following haploidentical peripheral blood hematopoietic stem cell transplantation.
Ball LM; Lankester AC; Bredius RG; Fibbe WE; van Tol MJ; Egeler RM
Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S35-8. PubMed ID: 15812528
[TBL] [Abstract][Full Text] [Related]
8. Cellular immune reconstitution after haploidentical transplantation in children.
Handgretinger R; Chen X; Pfeiffer M; Schumm M; Mueller I; Feuchtinger T; Hale G; Lang P
Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):59-65. PubMed ID: 18162222
[TBL] [Abstract][Full Text] [Related]
9. Selective T-cell depletion for haplotype-mismatched allogeneic stem cell transplantation.
Bastien JP; Roy J; Roy DC
Semin Oncol; 2012 Dec; 39(6):674-82. PubMed ID: 23206844
[TBL] [Abstract][Full Text] [Related]
10. Immune reconstitution after haematopoietic stem cell transplantation: obstacles and anticipated progress.
Cavazzana-Calvo M; André-Schmutz I; Dal Cortivo L; Neven B; Hacein-Bey-Abina S; Fischer A
Curr Opin Immunol; 2009 Oct; 21(5):544-8. PubMed ID: 19766472
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
12. Current status of haploidentical stem cell transplantation.
Dey BR; Spitzer TR
Br J Haematol; 2006 Nov; 135(4):423-37. PubMed ID: 16984391
[TBL] [Abstract][Full Text] [Related]
13. The history and future prospective of haplo-identical stem cell transplantation.
Handgretinger R; Lang P
Cytotherapy; 2008; 10(5):443-51. PubMed ID: 18615344
[TBL] [Abstract][Full Text] [Related]
14. Haploidentical peripheral blood stem cell transplantation with a combination of CD34 selection and T cell depletion as graft-versus-host disease prophylaxis in a patient with severe combined immunodeficiency.
Martín-Hernández MP; Arrieta R; Martínez A; García P; Jimenez-Yuste V; Hernandez-Navarro F
Bone Marrow Transplant; 1997 Nov; 20(9):797-9. PubMed ID: 9384486
[TBL] [Abstract][Full Text] [Related]
15. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
Huang X; Liu D
Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
[TBL] [Abstract][Full Text] [Related]
16. New approaches to graft engineering for haploidentical bone marrow transplantation.
Handgretinger R
Semin Oncol; 2012 Dec; 39(6):664-73. PubMed ID: 23206843
[TBL] [Abstract][Full Text] [Related]
17. Negative depletion of CD3(+) and TcRαβ(+) T cells.
Handgretinger R
Curr Opin Hematol; 2012 Nov; 19(6):434-9. PubMed ID: 22914586
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors.
Koh LP; Rizzieri DA; Chao NJ
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1249-67. PubMed ID: 17950913
[TBL] [Abstract][Full Text] [Related]
19. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
20. Haploidentical hematopoietic stem cell transplantation with a megadose T-cell-depleted graft: harnessing natural and adaptive immunity.
Aversa F; Martelli MF; Velardi A
Semin Oncol; 2012 Dec; 39(6):643-52. PubMed ID: 23206841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
